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Abstract: Growing evidence supports the hypothesis that the in utero environment can have profound
implications for fetal development and later life offspring health. Current theory suggests conditions
experienced in utero prepare, or “programme”, the fetus for its anticipated post-natal environment.
The mechanisms responsible for these programming events are poorly understood but are likely to
involve gene expression changes. Folate is essential for normal fetal development and inadequate
maternal folate supply during pregnancy has long term adverse effects for offspring. We tested the
hypothesis that folate depletion during pregnancy alters offspring programming through altered gene
expression. Female C57BL/6J mice were fed diets containing 2 mg or 0.4 mg folic acid/kg for 4 weeks
before mating and throughout pregnancy. At 17.5 day gestation, genome-wide gene expression was
measured in male fetal livers and placentas. In the fetal liver, 989 genes were expressed differentially
(555 up-regulated, 434 down-regulated) in response to maternal folate depletion, with 460 genes
expressed differentially (250 up-regulated, 255 down-regulated) in the placenta. Only 25 differentially
expressed genes were common between organs. Maternal folate intake during pregnancy influences
fetal gene expression in a highly organ specific manner which may reflect organ-specific functions.
Keywords: transcriptome; programming; developmental origins of health and disease; pregnancy; diet
1. Introduction
The developmental origins of health and disease (DOHaD) hypothesis proposes that in utero
and early life exposures can lead to altered programming of offspring. Such programming events
can cause permanent changes in organ development, physiology and metabolism leading to altered
disease risk in later life. Suboptimal nutrition, both under- and over-nutrition, during fetal and
neonatal development increases susceptibility to a wide range of diseases [1]. These observations
indicate a degree of plasticity during development, in which the fetal phenotype may be altered due
to environment cues [2] to prepare it for the anticipated post-natal environment [3]. The biological
mechanisms underlying this “programming” effect of nutrition during early life are poorly understood,
but are likely to involve changes in gene expression.
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The protective effect of adequate dietary folate intake and of folic acid supplementation during
pregnancy on risk of neural tube defects (NTDs) is well established [4,5]. Further, epidemiological
evidence suggests that adequate dietary folate intake or supplementation with folic acid during
pregnancy may reduce the risk of other congenital defects [6] and adverse pregnancy outcomes [7], as
well enhancing neurodevelopment [8] and reducing the risk of severe language delay [9], autism [10,11]
and some cancers (leukaemia [12–14], brain tumours [15,16] and neuroblastoma [17]) [18] in children.
In rodent models, folate deficiency during pregnancy can cause spontaneous abortion, teratogenic
effects in offspring, reduced litter number, and altered offspring body weight [19,20]. Sufficient
maternal folate intake during pregnancy is essential for successful pregnancy outcomes/normal fetal
development and for the long-term health of the offspring.
Folate, a B vitamin, is central to one-carbon metabolism which, in addition to formation of the
universal methyl donor, S-adenosyl-methionine (SAM), interacts with several other cellular pathways
including amino acid metabolism and biosynthesis of purine and pyrimidines [21]. SAM is critical for
the methylation of biological molecules including DNA, lipids and proteins. Epigenetic mechanisms
(including methylation of DNA and of histones) which regulate gene expression are susceptible to
modification via altered SAM availability in response to changes in folate intake (reviewed in [22]).
Therefore, we hypothesised that inadequate folate supply during pregnancy alters programming of
the offspring via changes in gene expression and that this is responsible for the observed adverse
effects of this maternal nutritional insult on pregnancy outcomes and offspring health in later life.
Mammals respond to inadequate nutrient supply by prioritising allocation of nutrients to specific
purposes [23,24] which may result in cell, tissue and organ differences in gene expression. Little is
known about such inter-organ differences in fetal gene expression in response to restricted folate
supply. We hypothesised that the fetal liver and placenta, which represent organs with long and
short-term consequences for the developing animal, would be subject to distinctly different responses
to folate depletion. To test these hypotheses, we quantified genome-wide gene expression patterns in
fetal liver and placenta in response to maternal folate depletion before, and throughout, pregnancy.
2. Experimental Section
2.1. Animal Husbandry and Experimental Diets
All animal procedures were approved by the Newcastle University Ethics Review Committee
and the UK Home Office (Project Licence number 60/3979) and have been described previously [25].
Animals were housed in the Comparative Biology Centre, Newcastle University at 20–22 ◦C and
with 12 h light and dark cycles. Fresh water was available ad libitum. Female C57BL/6J mice were
allocated at random to either a low folate (0.4 mg folic acid/kg diet) or normal folate diet (2 mg folic
acid/kg diet) (6 g of allocated diet was offered to each mouse per day), and maintained on this diet
for 4 weeks prior to mating. Diet compositions were modified from AIN-93G [26] and have been
described previously [25]. L-amino acids were used as a protein substitute. All ingredients, other
than folic acid, were included in both diets at the same concentrations to avoid potential confounding
through other dietary factors. The degree of folate depletion induced by feeding the diet containing
0.4 mg folic acid/kg was sufficient to impose a nutritional stress (evidenced by reduced circulating
concentrations of folate) but not so severe as to limit reproduction. The normal folate diet contained
2 mg folic acid/kg diet which is considered sufficient to support breeding and maintenance in this
species. Mice were time mated i.e., a male was added to a cage containing two females overnight and
removed the following morning. Pregnant females, identified by the presence of a vaginal plug, were
re-caged and offered 10 g/day of allocated diet throughout pregnancy. At 17.5 days gestation, dams
were killed for collection of blood and organs.
2.2. Sample Collection
Animals were anesthetised using gaseous isoflurane, blood was removed by cardiac puncture
and animals were killed by cervical dislocation. Blood was collected and stored in EDTA tubes.
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Whole blood 5-methyltetrahydrofolate (THF) and 5–10-methylTHF concentrations were measured by
liquid chromatography-tandem mass spectrometry (LC-MS/MS) and data reported previously [25].
The uterus, containing all fetuses and placentas, was removed and placed immediately in ice cold PBS.
The liver and placenta of each fetus were removed, weighed and snap frozen in liquid nitrogen and
stored at −80 ◦C until required for RNA extraction.
2.3. RNA Extraction
To avoid any potential influence of sex on resultant data, only male tissues were analysed. Fetal
sex was determined by polymerase chain reaction (PCR) of the sex determining region-Y (SRY) gene
using DNA extracted from embryonic tail tissue [25,27]. RNA was extracted from whole fetal livers
and placentas of males only using Tri-reagent (Sigma-Aldrich, Gillingham, Dorset, SP8 4XT, UK) and
following the manufacturer’s instructions. Briefly, 50 mg tissue was homogenised in 500 µL Tri-reagent
on ice. A further 500 µL Tri-reagent and 200 µL chloroform were added, then the sample was mixed by
inversion and incubated on ice for 5 min. Samples were then centrifuged at 13,500 rpm for 15 min at
4 ◦C. The upper aqueous phase was removed, RNA was precipitated by incubation on ice with 500 µL
isopropanol for 10 min, after which it was collected by centrifugation at 13,500 rpm for 10 min at 4 ◦C.
The supernatant fluid was removed and the pellet was washed with 1 mL 75% ethanol for 10 min
before centrifuging at 6000 rpm for 5 min at 4 ◦C. The supernatant fluid was removed, and the pellet
was allowed to dry for 10 min before resuspending the RNA in 40 µL water. Contaminating DNA
was removed using RQ1 DNase (Promega, Southampton, Hampshire, SO16 7NS, UK). RNA integrity
was checked on an agarose gel and concentration and purity were measured using a Nanodrop
spectrophotometer (Thermo Fisher, Waltham, MA, USA).
2.4. Gene Expression Arrays
RNA from each tissue was pooled for three male fetuses per litter (5 µg/fetus with a final
concentration of 500 ng/µL) and hybridised to a single array for a total of 12 litters (n = 6 per dietary
group) for each organ. Where a litter had more than three male fetuses, the three fetuses with weights
closest to the mean litter weight were analysed.
Genome-wide transcript abundance was determined by ServiceXS (Plesmanlaan 1/D, 2333 BZ
Leiden, The Netherlands) on the Affymetrix GeneChip platform with the NuGO mouse array
(NuGO_Mm1a520177). This array comprises over 24,000 probe sets, covering the majority of established
genes. Before the labelling process, the integrity of all RNA samples (RNA Integrity Number (RIN) > 8)
was confirmed using the Agilent 2100 Bioanalyser (Agilent Technologies, Stockport, Cheshire, SK8
3GY, UK). Output data were supplied as Affymetrix CEL files and imported into R (version 2.15.3)
using the Affy package [28]. Data from liver and placenta were pre-processed separately using gcRMA
background correction and quantile normalisation [29] to correct for batch effects and other technical
confounders. To maximize sensitivity and specificity, updated Entrez gene probe-set annotation was
used from the BrainArray project [30] (version 14.1.0) resulting in 16,270 re-annotated probesets mapping
to unique transcripts. Statistical analysis comparing the two diet groups was performed separately
for each organ using the empirical Bayes approach of the Limma package [31] which performs a
moderated t-test. On filtering genes for significant changes using False Discovery Rate (FDR) values
calculated using the Benjamini and Hochberg method (FDR < 0.05), no genes remained statistically
significant. Pathway analysis can in part replace FDR corrections by testing for the regulation of related
genes, which suffers less from oversampling. Genes were, therefore, considered to show a differential
expression relevant for further analysis in enrichment analysis in response to maternal folate depletion if
there was a significant (p < 0.05) increase or reduction of at least 1.2 fold. DAVID [32] was used to carry
out Gene Ontology enrichment analysis and to investigate KEGG pathways affected by maternal folate
depletion. The threshold for significance for Gene Ontology enrichment analysis was set at p < 0.05
(corrected for multiple testing), and at p < 0.05 (uncorrected) for KEGG pathway enrichment analysis.
Additional pathway analysis was carried out using PathVisio 3.2.0 and the curated pathway collection
of WikiPathways (download date: 1 September 2015), applying the same parameters for significant
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fold-change as stated above, imposing a Z score of 1.9 for significance to filter for probable changed
pathways. All raw and processed microarray data have been deposited in the ArrayExpress database
(accession ID E-MTAB-3940).
2.5. Validation of Gene Expression Changes Using Real-Time PCR
To confirm the gene expression changes observed in the microarray analysis, real-time PCR was
performed on each individual (i.e., not pooled) fetal RNA sample that was analysed by microarray
hybridisation, focusing on 13 gene targets. Target genes were selected on the basis of being the most
up or down regulated in the liver and placenta. Gene transcripts analysed in placental RNA were
Cyp21a1, Hbb-y, Slco1b2, Ptgs2, Vcan, Lrrn4, and Mettl7b and in fetal liver RNA were Asgr1, Hamp, Actc1,
Ckm, Tnnc2 and Smpx.
RNA (1 µg) was reverse transcribed using Quantitect Reverse Transcription kit (Qiagen, Cat No.
205313) according to the manufacturer’s instructions. Briefly, 1 µg of RNA was incubated with 2 µL
genomic DNA Wipeout buffer in a reaction volume of 14 µL at 42 ◦C for 2 min to remove any genomic
DNA. The mixture was then placed immediately on ice. RNA was incubated with 1 µL Quantiscript
reverse transcriptase, 1 µL RT primer mix and 4 µL Quantiscript RT buffer for 15 min at 42 ◦C, after
which time it was incubated at 95 ◦C for 3 min. The cDNA samples generated were then diluted 1:9
with water for use in real time PCR.
Prior to sample analysis, expression values, linearity and efficiency of each assay were determined
through cDNA standard curves completed for each transcript measured. Transcript levels of the
genes of interest were measured on a Roche Lightcycler 480 (Roche Applied Science, Burgess Hill,
West Sussex, RH15 9RY, UK) in a total reaction volume of 25 µL using 2.5 µL Quantitect sybr green
transcript specific primers (Qiagen, see Supplementary Materials Table S1 for details of manufacturer’s
individual catalogue numbers), 12.5 µL Quantitect SYBR green mix (Qiagen Cat. No. 204145), 1 µL
diluted cDNA and 9 µL water and cycling parameters 95 ◦C for 5 min (1 cycle); 95 ◦C for 10 s followed
by 60 ◦C for 30 s (40 cycles); followed by a final melt curve analysis and cooling to 40 ◦C. Using the
delta CT method, transcript levels of the genes of interest were normalised to GAPDH transcript levels
which were determined using the same procedure and parameters described.
2.6. In Silico Analysis of Gene Promoter Regions for Transcription Factor (TF) Binding Sites
Genomatix software (https://www.genomatix.de/v3.5 24 July 2015) was employed to obtain
promoter sequences for genes of interest using the Gene2Promoter function. Promoter sequences were
analysed for common transcription factor binding sites using the Common TFs function. Lists of TFs
belonging to the transcription factor binding site families identified were downloaded from Genomatix
and compared with fetal liver gene expression data.
2.7. Statistical Analysis
Statistical analysis of array data is described above. For all other datasets, data distributions were
examined by the Kolmogorov-Smirnov test and all datasets were normally distributed. Analysis of
variance (Statistical Package for the Social Sciences (SPSS) version 21, IBM, Armonk, New York 10504,
NY, USA) was used to examine the effects of diet on placental weight, placental efficiency and
gene expression analysis on data obtained from RT PCR analysis. p < 0.05 was considered
statistically significant.
3. Results
3.1. Influence of Maternal Folate Intake during Pregnancy on Fetal Weight, Liver Weight, Placental Weight and
Placental Efficiency
Data on the effects of maternal folate depletion on fetal weight and fetal liver weight have been
presented previously [25]. In addition, exposure to the Low Folate diet reduced maternal whole blood
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5’methyl THF concentration significantly (p < 0.001) with values of 666 (40.9) and 378 (50.0) nmol/L
for Normal and Low Folate diets respectively [25]. Maternal folate depletion increased fetal weight
but had no effect on weight of the fetal liver. There was no significant influence of maternal folate
intake during pregnancy on placental weight (mean placental weights were 107.0 mg and 107.3 mg for
normal (n = 56) and low (n = 37) folate groups respectively (p = 0.945)). Placental efficiency, calculated
by dividing fetal weight by placental weight, was not influenced by maternal folate depletion (mean
placental efficiencies were 7.9 and 9.1 for normal (n = 56) and low (n = 37) folate groups respectively
(p = 0.200)).
3.2. Influence of Maternal Folate Intake during Pregnancy on Gene Expression in the Fetal Liver
In the fetal liver, 989 genes were differentially expressed in response to maternal folate depletion,
comprising 555 up-regulated genes and 434 down-regulated genes (Supplementary Materials Table S2).
All raw and processed microarray data have been deposited in the ArrayExpress database (accession
ID E-MTAB-3940). Seventy three (7.4%) of these differentially expressed genes code for known
transcription factor proteins (see Supplementary Materials Table S3 for list of genes). Although the
majority (95.3%) of the gene expression changes were small (i.e., ranging from a fold change of 1.2–2),
the expression of 47 genes was changed by greater than two-fold (Table 1).
Whilst gene ontology analysis found no statistically significant influence on biological processes,
KEGG pathway analysis revealed that “Lysosome” and “Tight Junction” pathways were significantly
affected in the fetal liver in response to maternal folate depletion (Table 2). Analysis of WikiPathways
using PathVisio found 13 pathways in which a significant number of genes had altered expression in
the fetal liver in response to maternal folate depletion (Table 3).
3.3. Influence of Maternal Folate Intake during Pregnancy on Gene Expression in the Placenta
In the placenta, 460 genes were differentially expressed (250 up-regulated and 255 down-regulated)
in response to maternal folate depletion (Supplementary Materials Table S4). All raw and processed
microarray data have been deposited in the ArrayExpress database (accession ID E-MTAB-3940).
Twenty two (4.8%) of these differentially expressed genes code for known transcription factor proteins
(see Supplementary Materials Table S5 for list of genes). Of all the genes expressed differentially, only
three had a change in expression of greater than two-fold (Table 4), with the vast majority (99.4%) of
changes being small (i.e., ranging from 1.2 to 2 fold change).
Whilst gene ontology analysis found no statistically significant effects on biological processes in
placenta, KEGG pathway analysis revealed that “Amino sugar and nucleotide sugar metabolism”,
“Valine, leucine and isoleucine degradation” and “Complement and coagulation cascades” pathways
were significantly affected in the placenta in response to maternal folate depletion (Table 5).
Interrogation of WikiPathways using PathVisio found 13 pathways which were altered significantly in
response to maternal folate depletion (Table 6).
3.4. Comparison of Gene Expression Changes in the Placenta and Fetal Liver in Response to Maternal
Folate Depletion
More genes in the fetal liver than in the placenta had altered expression in response to maternal
folate intake during pregnancy (n = 989 and 460 respectively). Only 25 genes were common to the
data-sets for fetal liver and placenta (see Table 7 for gene list). The expected overlap between two
random subsets with elements of 989 and 460 respectively picked from a set of 16270 elements (the total
number of measured genes) is 28, hence the observed overlap of 25 genes is likely due to chance. Of the
genes found to respond to maternal folate in both placenta and fetal liver, only four displayed the same
direction of change in both organs, with 21 showing the opposite direction of change (Figure 1), which
suggests that finding expression changes in the same genes in the two organs may be due to chance.
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Table 1. Genes with greater than two-fold expression change in fetal liver in response to maternal folate depletion 1,2.
Gene Symbol Gene Name Ensembl ID Direction of Change Fold Change p Value FDR
Actc1 actin, alpha, cardiac muscle 1 ENSMUSG00000068614 Down 20.5 0.001 0.379
Ckm creatine kinase, muscle ENSMUSG00000030399 Down 14.8 0.001 0.379
Tnnc2 troponin C2, fast ENSMUSG00000017300 Down 14.0 0.015 0.458
Smpx small muscle protein, X-linked ENSMUSG00000041476 Down 13.4 0.001 0.379
Tnni2 troponin I, skeletal, fast 2 ENSMUSG00000031097 Down 9.1 0.016 0.460
Actn2 actinin alpha 2 ENSMUSG00000052374 Down 8.6 0.001 0.379
Atp1b4 ATPase, (Na+)/K+ transporting, beta 4 polypeptide ENSMUSG00000016327 Down 7.9 0.009 0.443
Tnnt3 troponin T3, skeletal, fast ENSMUSG00000061723 Down 7.6 0.016 0.461
Eno3 enolase 3, beta muscle ENSMUSG00000060600 Down 7.5 0.003 0.379
Tnni1 troponin I, skeletal, slow 1 ENSMUSG00000026418 Down 7.2 0.008 0.435
Myh8 myosin, heavy polypeptide 8, skeletal muscle, perinatal ENSMUSG00000055775 Down 6.9 0.024 0.487
Casq2 calsequestrin 2 ENSMUSG00000027861 Down 6.7 0.001 0.379
Mybpc1 myosin binding protein C, slow-type ENSMUSG00000020061 Down 6.6 0.022 0.477
Myh3 myosin, heavy polypeptide 3, skeletal muscle, embryonic ENSMUSG00000020908 Down 6.6 0.015 0.458
Ldb3 LIM domain binding 3 ENSMUSG00000021798 Down 6.3 0.002 0.379
Mylpf myosin light chain, phosphorylatable, fast skeletal muscle ENSMUSG00000030672 Down 6.1 0.021 0.477
Sln Sarcolipin ENSMUSG00000042045 Down 6.0 0.017 0.465
Myl4 myosin, light polypeptide 4 ENSMUSG00000061086 Down 5.4 0.005 0.407
Ckmt2 creatine kinase, mitochondrial 2 ENSMUSG00000021622 Down 4.9 0.007 0.435
Myot Myotilin ENSMUSG00000024471 Down 4.6 0.014 0.451
Csrp3 cysteine and glycine-rich protein 3 ENSMUSG00000030470 Down 4.3 0.017 0.465
Srl Sarcalumenin ENSMUSG00000022519 Down 4.1 0.005 0.407
Pgam2 phosphoglycerate mutase 2 ENSMUSG00000020475 Down 3.6 0.015 0.458
Atp2a1 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 ENSMUSG00000030730 Down 3.6 0.042 0.545
Tnnt1 troponin T1, skeletal, slow ENSMUSG00000064179 Down 3.4 0.023 0.481
Sh3bgr SH3-binding domain glutamic acid-rich protein ENSMUSG00000040666 Down 3.1 0.002 0.379
Itgb1bp2 integrin beta 1 binding protein 2 ENSMUSG00000031312 Down 2.9 0.023 0.481
Cdh11 cadherin 11 ENSMUSG00000031673 Down 2.6 0.012 0.447
Crh corticotropin releasing hormone ENSMUSG00000049796 Down 2.5 0.036 0.529
Fhl1 four and a half LIM domains 1 ENSMUSG00000023092 Down 2.5 0.002 0.379
Apobec2 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 ENSMUSG00000040694 Down 2.4 0.009 0.442
Egfl6 EGF-like-domain, multiple 6 ENSMUSG00000000402 Down 2.4 0.004 0.395
Myom1 myomesin 1 ENSMUSG00000024049 Down 2.4 0.029 0.498
Mlf1 myeloid leukemia factor 1 ENSMUSG00000048416 Down 2.3 0.020 0.476
Cav2 caveolin 2 ENSMUSG00000000058 Down 2.3 0.001 0.379
Shh sonic hedgehog ENSMUSG00000002633 Down 2.2 0.019 0.465
Slit2 slit homolog 2 (Drosophila) ENSMUSG00000031558 Down 2.2 0.003 0.379
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Table 1. Cont.
Gene Symbol Gene Name Ensembl ID Direction of Change Fold Change p Value FDR
Rps6ka6 ribosomal protein S6 kinase polypeptide 6 ENSMUSG00000025665 Down 2.1 0.034 0.526
Scn7a sodium channel, voltage-gated, type VII, alpha ENSMUSG00000034810 Down 2.1 0.020 0.476
Sparcl1 SPARC-like 1 ENSMUSG00000029309 Down 2.1 0.012 0.447
Nr1h4 nuclear receptor subfamily 1, group H, member 4 ENSMUSG00000047638 Up 2.0 0.001 0.379
Pemt phosphatidylethanolamine N-methyltransferase ENSMUSG00000000301 Up 2.1 0.021 0.477
Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 ENSMUSG00000037411 Up 2.1 0.001 0.379
LOC100503019 hypothetical protein LOC100503019 NA Up 2.5 0.018 0.465
Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ENSMUSG00000025479 Up 2.7 0.012 0.443
Asgr1 asialoglycoprotein receptor 1 ENSMUSG00000020884 Up 2.8 0.010 0.443
Hamp hepcidin antimicrobial peptide ENSMUSG00000050440 Up 3.3 0.001 0.379
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets.
Table 2. KEGG pathways in the fetal liver altered by maternal folate depletion during pregnancy 1.
KEGG Pathway Term Pathway Name Total Genes on Pathway Number of Altered Genes Differentially Expressed Genes p Value
mmu04142 Lysosome 119 12
Ap3m1 (ENSMUSG00000021824), Gm2a (ENSMUSG00000000594)
0.031
Atp6v0a1 (ENSMUSG00000019302), Naga (ENSMUSG00000022453)
Arsg (ENSMUSG00000020604), Gba (ENSMUSG00000028048)
Cd68 (ENSMUSG00000018774), Ap3s2 (ENSMUSG00000063801)
Gla (ENSMUSG00000031266), Dnase2b (ENSMUSG00000028185)
Galns (ENSMUSG00000015027), Gaa (ENSMUSG00000025579)
mmu04530 Tight junction 135 13
Tjp1 (ENSMUSG00000030516), B230120H23Rik (ENSMUSG00000004085)
0.033
Myh3 (ENSMUSG00000020908), Hcls1 (ENSMUSG00000022831)
Gnai3 (ENSMUSG00000000001), Myh8 (ENSMUSG00000055775)
Nras (ENSMUSG00000027852), Actn2 (ENSMUSG00000052374)
Ppp2r1a (ENSMUSG00000007564), Epb4.1l2 (ENSMUSG00000019978)
Mylpf (ENSMUSG00000030672), Spnb2 (ENSMUSG00000020315),
Akt2 (ENSMUSG00000004056)
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively.
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Table 3. WikiPathways in the fetal liver altered by maternal folate depletion during pregnancy 1,2 and identified using PathVisio.
Pathway Number of GenesAltered on Pathway
Number of Genes
Measured on Pathway
Total Number of
Genes on Pathway % Affected Z Score p-Value (Permuted)
Striated Muscle Contraction 16 32 46 50 9.35 <0.001
Adipogenesis genes 16 111 133 14 2.95 0.005
Fatty Acid Biosynthesis 5 21 26 24 2.93 0.011
Iron Homeostasis 3 10 16 30 2.77 0.013
TGF Beta Signaling Pathway 7 42 53 17 2.36 0.015
miR-1 in cardiac development 1 2 6 50 2.33 0.029
One carbon metabolism and related pathways 6 37 86 16 2.11 0.028
EPO Receptor Signaling 4 21 27 19 2.09 0.038
Spinal Cord Injury 11 85 110 13 2.04 0.035
Alanine and aspartate metabolism 2 8 43 25 1.94 0.038
Methylation 2 8 15 25 1.94 0.045
Osteoblast 2 8 14 25 1.94 0.040
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets.
Table 4. Genes with greater than two-fold expression change in the placenta in response to maternal low folate intake 1,2.
Gene Symbol Gene Name Ensembl ID Directionof Change
Fold
Change p Value FDR
Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 ENSMUSG00000024365 Down 2.5 0.002 0.999
Hbb-y hemoglobin Y, beta-like embryonic chain ENSMUSG00000052187 Down 2.2 0.035 0.999
Slco1b2 solute carrier organic anion transporter family, member 1b2 ENSMUSG00000030236 Down 2.1 0.011 0.999
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets.
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Table 5. KEGG pathways in the placenta altered by maternal folate depletion during pregnancy 1, 2.
KEGG
Pathway Term Pathway Name
Total Genes
on Pathway
Number of
Altered Genes Differentially Expressed Genes p Value
mmu00520 Amino sugar and nucleotidesugar metabolism 44 5
Gnpda2 (ENSMUSG00000029209), Pgm2 (ENSMUSG00000025791),
Uap1 (ENSMUSG00000026670), Gmppb (ENSMUSG00000070284),
Pgm3 (ENSMUSG00000056131)
0.017
mmu00280 Valine, leucine andisoleucine degradation 46 5
Mccc2 (ENSMUSG00000021646), Oxct2a (ENSMUSG00000076436),
Hsd17b10 (ENSMUSG00000025260), Bckdhb
(ENSMUSG00000032263), Abat (ENSMUSG00000057880)
0.019
mmu04610 Complement andcoagulation cascades 75 6
Cd55 (ENSMUSG00000026399), Serpina1b (ENSMUSG00000071178),
F11 (ENSMUSG00000031645), F2 (ENSMUSG00000027249), C9
(ENSMUSG00000022149), C3 (ENSMUSG00000024164)
0.026
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets.
Table 6. WikiPathways in the placenta altered by maternal folate depletion 1,2 during pregnancy and identified using PathVisio.
Pathway Number of GenesAltered on Pathway
Number of Genes
Measured on Pathway
Total Number of
Genes on Pathway % Affected Z Score p-Value (Permuted)
Complement Activation, Classical Pathway 3 13 19 23 3.77 0.002
Statin Pathway 3 16 29 19 3.26 >0.000
Alanine and aspartate metabolism 2 8 43 25 3.25 0.007
Glucocorticoid & Mineralocorticoid Metabolism 2 9 27 22 3 0.016
Selenium metabolism/Selenoproteins 3 18 49 17 2.98 0.015
Alzheimers Disease 6 54 91 11 2.98 0.006
Nuclear Receptors 4 31 38 13 2.79 0.015
Glucuronidation 2 10 33 20 2.78 0.012
Arachidonate Epoxygenase Epoxide Hydrolase 1 3 13 33 2.76 0.037
Polyol pathway 1 3 12 33 2.76 0.024
Complement and Coagulation Cascades 5 54 64 9 2.24 0.015
Acetylcholine Synthesis 1 5 18 20 1.97 0.050
Aflatoxin B1 metabolism 1 5 11 20 1.97 0.037
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets.
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Table 7. Genes differentially expressed in both fetal liver and placental organs in response to maternal folate depletion 1,2,3.
Gene Symbol Ensembl ID Expression fold Changein Fetal Liver p Value for Fetal Liver
Expression Fold Change
in Placenta p Value for Placenta
A830035A12RIK NA 1.5 0.025 −1.5 0.019
Aadat ENSMUSG00000057228 −1.3 0.033 −1.3 0.031
Akr7a5 ENSMUSG00000028743 1.2 0.023 −1.3 0.003
Apon ENSMUSG00000051716 1.4 0.019 −1.4 0.021
Atp6v0a1 ENSMUSG00000019302 1.2 0.028 −1.3 0.007
Atrnl1 ENSMUSG00000054843 −1.3 0.013 1.3 0.008
Bcas3 ENSMUSG00000059439 1.2 0.034 −1.2 0.035
Col15a1 ENSMUSG00000028339 −1.3 0.013 −1.2 0.029
Cyld ENSMUSG00000036712 −1.3 0.030 1.3 0.024
E130309D02RIK ENSMUSG00000039244 1.2 0.015 −1.2 0.027
Fkbp8 ENSMUSG00000019428 1.2 0.045 −1.3 0.020
Inpp1 ENSMUSG00000026102 1.2 0.019 −1.2 0.026
Itgb4 ENSMUSG00000020758 1.3 0.027 −1.2 0.039
Med6 ENSMUSG00000002679 −1.4 0.009 1.3 0.029
Nubpl ENSMUSG00000035142 1.6 0.014 1.5 0.040
Oxct2a ENSMUSG00000076436 −1.3 0.024 1.5 0.004
Pgm3 ENSMUSG00000056131 1.2 0.045 −1.3 0.028
Prtg ENSMUSG00000036030 1.3 0.026 1.2 0.048
Rbp2 ENSMUSG00000032454 1.5 0.036 −1.9 0.001
Sepx1 ENSMUSG00000075705 1.2 0.040 −1.3 0.026
Slc13a3 ENSMUSG00000018459 1.6 0.003 −1.4 0.018
Slc39a5 ENSMUSG00000039878 1.4 0.049 −1.4 0.037
Slc48a1 ENSMUSG00000081534 1.3 0.012 −1.2 0.041
Slc6a13 ENSMUSG00000030108 1.3 0.021 −1.2 0.048
Tomm40 ENSMUSG00000002984 1.4 0.021 −1.5 0.001
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each comparison, data were obtained from three male fetuses from each of six litters
from dams fed either the Low or Normal folate diets; 3 A negative fold change indicates lower expression in offspring from dams fed the Low folate diet.
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No common KEGG pathways were significantly influenced by maternal folate intake in both
the liver and placenta (Tables 2 and 5). Use of PathVisio to interrogate WikiPathways revealed that
“Alanine and aspartate metabolism” may be altered in both the fetal liver and the placenta of offspring
of folate depleted mothers (Tables 3 and 6). However, different genes in the pathway were differentially
expressed in response to maternal folate depletion in the two tissues. In the fetal liver Agxt and Pcx
were up-regulated in response to maternal folate depletion, whilst in the placenta Abat and Asl were
down regulated.
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3.5. Validation of Gene Expression Data from Array Analysis by RT-qPCR Analysis
For a subset of genes from both liver and placenta which showed altered expression in response
to maternal folat depletion using micr array analysis, ata were validated by RT-qPCR. For fetal
liver, where the large t fold change in response to maternal fol te depletion were found in down
regulated genes, we selected the four ost down regulated genes i.e., Actc1, Ckm, Tnn2 and Smpx.
In addition, we analysed the two most up regulated genes i.e., Hamp and Asgr1. All genes showed the
same direction of change using both methods (Table 8) but for 5/6 genes measured by RT-qPCR the
change in expression was not statistically significant.
For placenta, fold changes in expression for up- and down-regulated genes in response to maternal
folate depletion were similar and so the three genes with the largest fold changes in each direction
were selected for validation analysis i.e., Cyp21a1, Hbb-y and Slco1b2 for down-regulated genes and
Ptgs2, Vcan d Lrrn4 for up-regulated genes. In addition, a gene of particular i t rest, Mettl7b,
was also selected for RT-PCR analysis. This gene encodes the protein methyltransferase-like 7B,
and is likely to have methyltransferase activity (inferred through sequence similarity with other
protein methyltransferases (http://www.uniprot.org/uniprot/Q6UX53)), and thus may have a role
in epigenetic regulation of gene expression. All seven genes showed the same directional changes in
expression in response to maternal folate depletion when assayed by RT-qPCR and by microarray but
for 6/7 genes measured by RT-qPCR the change in expression was not statistically significant (Table 9).
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Table 8. RT-qPCR expression analysis of selected genes which were differentially expressed in fetal
liver in response to maternal folate depletion 1,2 when assayed by microarray.
Gene
Name
Mean
Expression Low
Folate Group
SEM
Mean Expression
Normal
Folate Group
SEM p Value
Direction of Change
in Agreement
with Array
Asgr1 0.35 0.07 0.12 0.07 0.050 Yes
Hamp 4.00 0.75 1.73 0.75 0.058 Yes
Actc1 3.63 3.04 8.29 3.04 0.305 Yes
Ckm 1.12 0.95 3.30 0.95 0.134 Yes
Tnnc2 0.51 0.66 2.39 0.66 0.073 Yes
Smpx 0.11 0.09 0.38 0.09 0.066 Yes
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each
comparison, data were obtained from three male fetuses from each of six litters from dams fed either the Low or
Normal folate diets. Expression values are in arbitrary units calculated using the delta CT method; GAPDH
was used as the reference gene. Expression levels were quantified in individual fetuses (n = 18 per group) with
mean expression levels calculated for individuals litters (n = 6 per group) for use in statistical analyses to match
procedures used for array data.
Table 9. RT-qPCR expression analysis of selected genes which were differentially expressed in placenta
in response to maternal folate depletion 1,2 when assayed by microarray. Expression values are in
arbitrary units calculated using the delta cycle threshold (CT) method. GAPDH was used as the
reference gene. Expression levels were quantified in individual fetuses (n = 18 per group) with mean
expression levels calculated for individuals litters (n = 6 per group) for use in statistical analyses to
match procedures used for array data.
Gene
Name
Mean
Expression Low
Folate Group
SEM
Mean Expression
Normal
Folate Group
SEM p Value
Direction of Change
in Agreement
with Array
Cyp21a1 0.55 0.13 0.88 0.13 0.118 Yes
Hbb-y 0.39 0.16 0.83 0.16 0.076 Yes
Slco1b2 0.29 0.08 0.49 0.08 0.106 Yes
Ptgs2 0.31 0.03 0.22 0.03 0.030 Yes
Vcan 0.66 0.09 0.46 0.09 0.144 Yes
Lrrn4 0.05 0.01 0.03 0.01 0.118 Yes
Mettl7b 3.07 0.61 4.83 0.61 0.068 Yes
1 The Low and Normal folate diets contained 0.4 and 2.0 mg folic acid/kg diet respectively; 2 For each
comparison, data were obtained from three male fetuses from each of six litters from dams fed either the Low or
Normal folate diet.
3.6. Comparison of Gene Expression Changes in Fetal Liver in Response to Maternal Folate Depletion with
Similar Published Transcriptomic Studies
Previous studies have reported gene expression changes at the transcriptomic level in the liver of
rodents in response to diets low in folate [33–35]. Although several aspects of design differ between
studies (summarised in Table 10), to identify a key set of genes in the liver that respond to changes in
folate intake (or more broadly, changes in one carbon metabolism), we compared reported changes
in gene expression between our data and three other studies [33–35]. Of the 989 genes which were
differentially expressed in the fetal liver in response to maternal folate depletion in our study, 4,
89, 90 and 239 genes were also found to be differentially expressed in CBA mice, BALB/c mice,
CBA/Ca mice and Wistar rats respectively [33–35] (full list of these genes for individual studies are in
Supplementary Materials Table S6). Comparison of the differentially expressed genes from all studies
revealed a set of 21 key genes whose expression was affected by altered folate/methyl donor intake in
at least four of the five data sets (see Table 11). Importantly, none of the 25 genes which we found were
expressed differentially in both fetal liver and placenta in response to maternal folate depletion are in
this list of 21 genes.
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Table 10. Overview of experimental designs of studies investigating the influence of folate/methyl donor intake on genome wide gene expression in the liver.
Study Model Diets Period of Exposure Arrays
This study Male C57Bl6J mice
2 mg folic acid/kg OR 4 weeks prior to mating to
17.5 days gestation
NuGO mouse array
(NuGO_Mm1a520177)0.4 mg folic acid/kg
Champier et al. [33] Male CBA mice
8 mg folic acid + 10 g of succinylsulfathiazole/kg OR
8–12 weeks of age CodeLinkUniset Mouse Whole
Genome bioarrays0 mg folic acid + 10 g of succinylsulfathiazole/kg
Glen et al. [35] Male BALB/c & CBA/Ca mice
Low methionine (0.18%, w/w) & lacking choline & folic acid OR
4–12 weeks of age NimbleGen 12 × 135 K Mouse
Expression ArrayLow methionine (0.18%, w/w) & supplemented with choline & folic acid
Chen et al. [34] Wistar rats
Standard food OR 1 month before pregnancy to
21 days post-weaning Agilent ArraysDiet without vitamin B12 & folate
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Table 11. Genes which were differentially expressed in response to low dietary folate/methyl donor
intake in the liver across multiple studies 1.
Gene Differentially Expressed
Gene Symbol McKay et al. Champier et al. [33] Glen et al. [35](BALB/c Mice)
Glen et al. [35]
(CBA/Ca Mice) Chen et al. [34]
ACOT2 Y N Y Y Y
COL6A2 Y N Y Y Y
CSTB Y N Y Y Y
DCTD Y N Y Y Y
ENTPD2 Y N Y Y Y
FETUB Y N Y Y Y
FGF21 N Y Y Y Y
IL7R Y N Y Y Y
JUB Y N Y Y Y
LTBP2 Y N Y Y Y
OXCT1 Y N Y Y Y
RHBDF1 Y N Y Y Y
RUNX3 Y N Y Y Y
SERPINE1 Y N Y Y Y
SLC15A3 Y N Y Y Y
SLC30A10 Y N Y Y Y
SLC39A5 Y N Y Y Y
SLC41A3 Y N Y Y Y
SLPI Y N Y Y Y
SORCS2 Y N Y Y Y
TMIE Y N Y Y Y
1 For details of diet compositions, please see Table 10. Y = Yes; N = No.
3.7. In Silico Analysis of Promoter Regions of Key Folate/Methyl Donor Responsive Genes for Transcription
Factor Binding Sites
For these 21 genes found to be affected robustly in liver by altered folate supply (Table 11),
76 unique promoter regions were found for 130 transcripts using the Gene2Promoter function in
Genomatix (data not shown). Transcription factor binding sites for five families of transcription factors
were present in 90% of the promoters investigated; ETS1 factors (ETSF), Kruppel like transcription
factors (KLFS), Nuclear receptor subfamily 2 factors (NR2F), RXR heterodimer binding site (RXRF)
and SOX/SRY sex/testis determining and related HMG box factors (SORY). Of these, the RXRF
transcription factors had binding sites in all 76 analysed promoters. TFs belonging to the five identified
families were compared with TFs found to be differentially expressed in the fetal liver and five TFs
were found to overlap viz. Elk3, Nr2c1, Nr2f1, Rxra, and Sox30.
However the same analysis on randomly-selected sets of 21 genes that were affected by folate
supply from each of the five studies plus two sets of 21 genes that did not respond to maternal folate
supply revealed similar occurrence rates for these same transcription factor binding sites. Thus, this
analysis identified no potential transcriptional regulatory mechanisms which may be responsible
exclusively for coordinating the liver-specific changes in expression of these key genes in response to
folate supply.
4. Discussion
Here we describe gene expression changes at the transcriptome level in the placenta and fetal liver
in response to maternal folate depletion before mating and throughout pregnancy. Ames’ triage theory
posits that if availability of a specific nutrient is inadequate, Darwinian processes ensure that essential
functions, i.e., those required for short-term survival and/or reproduction, dependent on that nutrient
that are protected at the expense of those functions that are less essential i.e., where reduced function
does not have short term negative consequences. However, such prioritisation of some most critical
(short-term) functions may impact adversely on other functions which may have long-term insidious
effects that increase risk of diseases associated with ageing [23,24]. In response to inadequate maternal
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folate intake during pregnancy, we hypothesised that, due to different organ-specific functions,
individual fetal organs would implement differential prioritisation hierarchies and thus display
differential gene expression changes in response to folate depletion. We chose to investigate gene
expression in the liver and placenta as examples of organs with very different roles in mammalian
function across the lifecourse. In addition, the liver represents a major site for folate storage and
metabolism, whilst the placenta (containing both maternal and fetal cells) is the route for delivery of
nutrients (including folate) from the dam to the fetus during development. Our observations support
our hypothesis that specific fetal organs exhibit specific transcriptional responses to maternal folate
depletion. It is plausible that these organ-specific changes in gene expression are due to differential
pathway prioritisation in each organ which reflect their contrasting functions.
The primary function of the placenta is the transfer of nutrients to the fetus, so it is essential
that this function is protected to support fetal growth and development. In response to maternal
folate depletion, we saw no changes in pathways associated with nutrient transport, suggesting that
placental transfer of nutrients to the fetus was protected despite the reduced maternal folate intake.
We observed no teratogenic effects of this reduced nutrient supply on the offspring [25]. It is important
to note that we analysed whole placental samples containing both maternal and fetal cell populations
and so we are unable to determine the cellular origin of the observed expression changes.
The liver is a highly metabolic organ responsible for a wide range of functions that are important
at all life stages and include defence of the body against xenobiotics, assisting with digestion and
with metabolism of absorbed nutrients, regulating blood lipids, synthesis of a wide range of secreted
proteins and hormonal regulation. As such, during periods of undernutrition, it may not be possible
for the liver to maintain all important functions, so that those functions essential for short-term survival
and/or reproduction may be prioritised. The sequela is that some functions not critical for short-term
survival but which are important for long term health may be de-prioritised leading to impaired
function which may have significant long-term adverse effects for the organism. We observed that
maternal folate depletion altered several processes and pathways, each of which could impact adversely
on long-term liver function and organismal health. These included “adipogenesis genes”, “fatty
acid biosynthesis” and “iron homeostasis” pathways. Whilst only one time point was investigated
here (so that we are unable to comment on long-term gene expression changes or phenotypic
outcomes), these observations are consistent with the fact that diets deficient in folate and choline can
induce non-alcoholic fatty liver disease (NAFLD) in rodent models [36]. We observed up-regulation
of genes involved in “fatty acid biosynthesis” (5/5 differentially expressed genes present on the
pathway), and an abundance of up-regulated genes involved in the “adipogenesis genes” pathway
(10/16 differentially expressed genes present on the pathway). Up-regulation of these genes may
result in overall up-regulation of the pathways that potentially could result in altered hepatic fatty
acid metabolism in offspring. Indeed, we observed that when the offspring of folate depleted dams
were fed a high fat diet from weaning [37], they had significantly increased plasma triacylglycerol
(TAG) concentrations whilst plasma TAG concentrations were unaffected in the offspring of folate
replete dams [37]. Taken together, these data suggest that maternal folate depletion results in an altered
response to high fat feeding which may be via programmed transcriptional changes in pathways
associated with fat metabolism in the liver.
This analysis has focussed on the genes which were differentially expressed in the liver and in the
placenta in response to maternal folate depletion. However, it is important to recognise that there are
alternative explanations for genes which did not change in response to this nutritional insult. Whilst
such unaltered genes may be components of pathways which are especially critical to that particular
organ, it is also possible that these genes are simply unresponsive to folate supply. The present study
design is unable to distinguish between these alternatives.
It is important to highlight that most of the gene expression changes observed in this study
were relatively small and not statistically significant when applying the more stringent FDR value so
that these data should be interpreted with caution. However, our observations are consistent with
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findings from other studies [33,34] and confirms the subtle, but pervasive, effects on gene expression
of folate/methyl donor depletion. Furthermore, it is pertinent to point out that our gene expression
studies were undertaken in male offspring only and it is possible, if theoretically unlikely, that effects
could be different in females.
Whilst we show clearly that folate responsive gene expression changes are organ specific, the
mechanisms behind the observed organ specific expression changes are less clear. A plausible
mechanistic explanation could be based on inter-organ differences in expression of transcription
factors (TFs) when exposed to inadequate folate intake. We tested this hypothesis by identifying all
TFs which were differentially expressed in the liver and in the placenta in response to maternal folate
depletion. In the fetal liver, we found that expression of 73 TFs differed in folate replete vs. folate
depleted offspring, which accounted for 7.4% of the altered genes. In contrast, in the placenta only
22 TFs (4.8% of altered genes) displayed altered expression. Consistent with the idea that organ-specific
changes in gene expression profiles are driven by organ-specific changes in TF expression, there was
very little overlap between the TFs that were altered in liver and placenta—only one TF, Med6, was
common between the organs.
It is plausible that changes in epigenetic processes are responsible for the organ-specific patterns
in gene expression in response to folate depletion. Epigenetic marks, including DNA methylation, are
modifiable by diet and other environmental factors and constitute an important and flexible system for
regulating gene expression [38,39]. Folate is central to one-carbon metabolism and the formation of the
universal methyl donor SAM, which is critical for the methylation of biological molecules including
DNA. Indeed the influence of dietary folate intake on DNA methylation patterns has been reported
widely [25,34,40–42] and may be responsible for the organ specific folate responsive gene expression
changes observed here.
Although previous studies have reported gene specific expression changes in the rat placenta in
response to increased levels of folate in the maternal diet [42,43], to the best of our knowledge this
is the first report describing gene expression changes in response to low maternal folate (or methyl
donor) intake in this organ, and the first study to investigate this at the transcriptomic level. However,
previous studies have used transcriptomic approaches to investigate gene expression changes in the
liver in response to low folate-containing diets [33–36,44,45] so we compared our data with outcomes
from these studies. Whilst there were differences in gene expression profiles between studies, likely
to be due to differences in rodent models, diet composition, duration and timing of the nutrient
insult and the particular transcriptomic approaches employed (Table 10), we uncovered a key set
of genes which were differentially expressed in the liver in response to low dietary folate/methyl
donor intake across multiple studies (Table 11). Importantly, expression of none of these genes was
altered in placenta by maternal folate depletion, indicating that these changes reflect a liver-specific
response rather than being genes that are generally malleable in response to perturbation in folate
supply. Moreover, this observation substantiates our suggestion that the transcriptome responses of
fetal liver and placenta to folate restriction are distinct and physiologically-appropriate. Of the key set
of 21 genes differentially expressed across multiple studies (Table 11), the use of DAVID [32] to carry
out Gene Ontology enrichment analysis suggested that three genes are involved in wound healing i.e.,
JUB, ENTPD2 and SERPINE1 and, thus, altered transcription of genes associated with wound healing
may help explain the observed association between low methyl donor intake and liver damage [36].
Furthermore, the discovery of these key folate responsive genes may provide candidate biomarkers
for future studies of folate adequacy. Such studies should test the effects of different doses of folate
without potential confounding from other dietary factors which may have been an issue in some of the
studies included in Table 10.
To investigate potential mechanisms through which expression of these key genes in the liver are
altered in response to methyl donor intake, the promoter regions were interrogated for the presence of
common transcription factor binding sites. Whilst binding sites for five families of transcription factors
were found to be highly represented in the promoters of these 21 genes, similar occurrence rates of
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these same transcription factor binding sites were also observed when seven randomly selected sets of
genes were analysed. This suggests that this specific set of TFs is not responsible for co-ordinating
transcriptional responses to maternal folate/methyl-donor supply in the liver. However, it is possible
that there are regulatory regions outside the promoters of the genes investigated here which would
merit investigation in future studies.
5. Conclusions
The data presented here suggest that maternal folate status during pregnancy influences gene
expression in the fetus in a highly organ-specific manner. We hypothesise that this organ specificity
is a rational response to limited nutrient supply which protects the most essential functions of each
individual organ for short term survival (and reproduction), at the expense of less immediately
essential processes which may lead to long-term adverse health sequelae. However, as we have noted
above, there are viable alternative explanations for our observations. Our observations are consistent
with the DOHaD hypothesis and suggest a plausible mechanism by which inadequate folate supply
during early development leads to changes in gene expression to protect functions of the liver that
are appropriate in this particular developmental and nutritional context, but that may contribute
to the aetiology of cardiometabolic diseases if the postnatal environment is such that these changes
become disadvantageous.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/10/661/s1,
Table S1: Details of manufacturer’s product codes for primers used to determine gene transcript levels by RT-qPCR,
Table S2: List of genes differentially expressed in the fetal liver in reponse to low maternal folate. Genes were
considered to be significantly differentially expressed in response to low maternal folate if (a) the p value for
t-test between dietary groups was < 0.05 and (b) if there was a fold change of ±1.2, Table S3: List of genes
encoding transcription factors differentially expressed in the fetal liver in reponse to low maternal folate. Genes
were considered to be significantly differentially expressed in response to low maternal folate if (a) the p value
for t-test between dietary groups was < 0.05 and (b) if there was a fold change of ±1.2. B1, Table S4: List of
genes differentially expressed in the placenta in reponse to low maternal folate. Genes were considered to be
significantly differentially expressed in response to low maternal folate if (a) the p value for t-test between dietary
groups was < 0.05 and (b) if there was a fold change of ±1.2.D1, Table S5: List of genes encoding transcription
factors differentially expressed in the placenta in reponse to low maternal folate. Genes were considered to be
significantly differentially expressed in response to low maternal folate if (a) the p value for t-test between dietary
groups was < 0.05 and (b) if there was a fold change of ±1.2, Table S6: Lists of genes found in in common with
other published data sets. Genes found to be differentially expressed in response to maternal folate depletion in
the fetal liver were compared to other published gene lists where diets low in folate were reported to alter gene
expression in the liver.
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